SNN (SNN) Stock Analysis

SNN (SNN) is a publicly traded company in the HEALTHCARE sector. It trades at $29.37, carries a market capitalization of $12.53B, a price-to-earnings ratio of 20.62, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for SNN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

Market Sentiment

SNN currently has a Bullish sentiment score of 0.30.

About SNN

Smith & Nephew plc (SNN) is a leading global medical technology company specializing in the development, manufacturing, and marketing of advanced medical devices across various sectors, including orthopedics, advanced wound management, and sports medicine. Headquartered in Watford, United Kingdom, Smith & Nephew leverages innovative technologies to enhance patient outcomes and drive efficiency in healthcare. With a strong commitment to research and development, the company continuously seeks ...

GNG Research Analysis

GNG Research scores SNN (SNN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNN.

Frequently Asked Questions

What is SNN's current dividend yield?

SNN (SNN) has a current dividend yield of 0.03%.

Does SNN pay dividends?

Yes, SNN pays dividends with a current yield of 0.03%.

What is SNN's P/E ratio?

SNN has a price-to-earnings (P/E) ratio of 20.62.

What is SNN's market cap?

SNN (SNN) has a market capitalization of $12.53B with a current stock price of $29.37.